Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Stage III breast cancer survivor Amanda Enayati turned her life around by seeking stories of women who beat the odds.
She doesn’t want to know when her time is up.
The novel immune-enhancing antibody delays disease progression, especially in people with a common genetic variant.
Angela “Jersi” Baker, 48, of Charlotte, North Carolina, has found a new life as a model promoting metastatic breast cancer awareness.
Removal of the primary breast tumor may be warranted in women who respond well to targeted therapies.
Robert P. Gaynes, MD, is an infectious disease specialist at Emory University School of Medicine in Atlanta.
Recently approved CDK4/6 inhibitor plus hormone therapy extends overall survival by about a third.
Piqray plus Faslodex prolonged progression-free survival for metastatic breast cancer patients with PIK3CA gene mutation.
Here’s a list of the approved drugs to treat breast cancer. Click on any of the medications for more info on dosing, side effects and...
Black women, as well as those with Medicaid or no insurance, were less likely to receive surgery and more likely to die.
Ibrance appears safe and effective for men in real-world use.
Until now, there had been little opportunity to note the effects of anti-estrogen therapy on brain metastases resulting from breast cancer.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.